Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hansen Medical Inc (HNSN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hansen Medical Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1276591.
Total stock buying since 2014: $27,433,708.
Total stock sales since 2014: $3,444.
Total stock option exercises since 2014: $251,000.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2016 | 0 | $0 | 923 | $3,444 | 368,771 | $0 |
2015 | 42,524,008 | $27,277,692 | 0 | $0 | 12,222 | $0 |
2014 | 164,932 | $156,016 | 0 | $0 | 222,126 | $251,000 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2016-07 | 0 | $0 | 0 | $0 | 366,923 | $0 |
2016-06 | 0 | $0 | 762 | $3,040 | 1,848 | $0 |
2016-03 | 0 | $0 | 161 | $404 | 0 | $0 |
2015-12 | 0 | $0 | 0 | $0 | 1,849 | $0 |
2015-09 | 0 | $0 | 0 | $0 | 2,920 | $0 |
2015-06 | 0 | $0 | 0 | $0 | 7,453 | $0 |
2015-05 | 42,500,931 | $12,277,642 | 0 | $0 | 0 | $0 |
2015-03 | 23,077 | $15,000,050 | 0 | $0 | 0 | $0 |
2014-12 | 40,000 | $28,550 | 0 | $0 | 0 | $0 |
2014-11 | 75,000 | $62,025 | 0 | $0 | 0 | $0 |
2014-08 | 0 | $0 | 0 | $0 | 222,126 | $251,000 |
2014-05 | 49,932 | $65,441 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-07-27 | Sheahan Brian (VP, Regulatory, Clinical & QA) | Option Ex | 29,156 | .00 | 0 |
2016-07-27 | Vance Cary Guy (President and CEO) | Option Ex | 220,289 | .00 | 0 |
2016-07-27 | Lowe Christopher P. (Interim CFO) | Option Ex | 100,000 | .00 | 0 |
2016-07-27 | Cathcart Robert O (SVP, Global Sales) | Option Ex | 17,478 | .00 | 0 |
2016-06-08 | Sheahan Brian (VP, Regulatory, Clinical & QA) | Sale | 166 | 3.99 | 662 |
2016-06-08 | Vance Cary Guy (President and CEO) | Sale | 596 | 3.99 | 2,378 |
2016-06-01 | Sheahan Brian (VP, Regulatory, Clinical & QA) | Option Ex | 357 | .00 | 0 |
2016-06-01 | Vance Cary Guy (President and CEO) | Option Ex | 1,491 | .00 | 0 |
2016-03-07 | Sheahan Brian (VP, Regulatory, Clinical & QA) | Sale | 161 | 2.51 | 404 |
2015-12-02 | Vance Cary Guy (President and CEO) | Option Ex | 1,491 | .00 | 0 |
2015-12-01 | Sheahan Brian (VP, Regulatory, Clinical & QA) | Option Ex | 358 | .00 | 0 |
2015-09-22 | Vance Cary Guy (President and CEO) | Option Ex | 1,491 | .00 | 0 |
2015-09-01 | Sheahan Brian (VP, Regulatory, Clinical & QA) | Option Ex | 1,429 | .00 | 0 |
2015-06-26 | Vance Cary Guy (President and CEO) | Option Ex | 1,491 | .00 | 0 |
2015-06-24 | Vance Cary Guy (President and CEO) | Option Ex | 5,962 | .00 | 0 |
2015-05-12 | Schuler Family Foundation (10% Owner) | Buy | 23,612,250 | .00 | 0 |
2015-05-12 | Oracle Associates Llc | Buy | 18,888,681 | .65 | 12,277,642 |
2015-03-09 | Schuler Family Foundation (10% Owner) | Buy | 23,077 | 650.00 | 15,000,050 |
2014-12-10 | Yared Nadim (Director) | Buy | 15,000 | .65 | 9,750 |
2014-12-03 | Sutton William Mitchell (Chief Operating Officer) | Buy | 25,000 | .75 | 18,800 |
2014-11-12 | Vance Cary Guy (President and CEO) | Buy | 75,000 | .83 | 62,025 |
2014-08-25 | Yared Nadim (Director) | Option Ex | 9,756 | 1.13 | 11,024 |
2014-08-25 | Bowen Marjorie L. (Director) | Option Ex | 44,566 | 1.13 | 50,359 |
2014-08-25 | Hykes Kevin (Director) | Option Ex | 22,764 | 1.13 | 25,723 |
2014-08-25 | Newman Stephen L (Director) | Option Ex | 65,040 | 1.13 | 73,495 |
2014-08-25 | Rohn William R (Director) | Option Ex | 80,000 | 1.13 | 90,399 |
2014-05-20 | Lowe Christopher P. (Interim CEO) | Buy | 20,000 | 1.45 | 28,900 |
2014-05-13 | Yared Nadim (Director) | Buy | 2,143 | 1.19 | 2,550 |
2014-05-13 | Bowen Marjorie L. (Director) | Buy | 9,789 | 1.27 | 12,471 |
2014-05-13 | Newman Stephen L (Director) | Buy | 8,000 | 1.19 | 9,520 |
2014-05-13 | Eagle Michael L (Director) | Buy | 10,000 | 1.20 | 12,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of HNSN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hansen Medical Inc (symbol HNSN, CIK number 1276591) see the Securities and Exchange Commission (SEC) website.